|
| 37542303 | The interwoven fibril-like structure of amyloid-beta plaques in mouse brain tissue visualized using super-resolution STED microscopy. | | 2023 |
| 36253511 | Lecanemab, Aducanumab, and Gantenerumab - Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease. | | 2023 |
| 38084203 | A light at the end of the tunnel - from mutation identification to a potential treatment for Alzheimer's disease. | | 2023 |
| 37559953 | Reduction of brain stem pathology and transient amelioration of early cognitive symptoms in transgenic mice treated with a monoclonal antibody against α-synuclein oligomers/protofibrils. | | 2023 |
| 36994753 | The amyloid-β pathway in Alzheimer's disease: a plain language summary. | Neurodegener Dis Manag | 2023 |
| 35120450 | Mutation analysis of disease causing genes in patients with early onset or familial forms of Alzheimer's disease and frontotemporal dementia. | BMC Genomics | 2022 |
| 36343257 | Aβ and tau prions feature in the neuropathogenesis of Down syndrome. | Proc Natl Acad Sci U S A | 2022 |
| 35598024 | Correction to: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody. | Alzheimers Res Ther | 2022 |
| 34380771 | The <i>Uppsala APP</i> deletion causes early onset autosomal dominant Alzheimer's disease by altering APP processing and increasing amyloid β fibril formation. | Sci Transl Med | 2021 |
| 33971986 | Heparanase overexpression impedes perivascular clearance of amyloid-β from murine brain: relevance to Alzheimer's disease. | Acta neuropathologica communications | 2021 |
| 33848613 | Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains. | Neuroscience Letters | 2021 |
| 33727701 | Publisher Correction: Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals. | Nat Genet | 2021 |
| 34091073 | Elevated soluble amyloid beta protofibrils in Down syndrome and Alzheimer's disease. | Mol Cell Neurosci | 2021 |
| 33865446 | A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody. | Alzheimers Res Ther | 2021 |
| 34579778 | Novel multivalent design of a monoclonal antibody improves binding strength to soluble aggregates of amyloid beta. | Translational Neurodegeneration | 2021 |
| 34737044 | ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's disease. | Neurobiology of Disease | 2021 |
| 34456336 | The Amyloid-β Pathway in Alzheimer's Disease. | Mol Psychiatry | 2021 |
| 33230300 | Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals. | Nat Genet | 2020 |
| 32154904 | [Alzheimer's disease - the most common cause of dementia]. | Lakartidningen | 2020 |
| 31654039 | Longitudinal changes in the frequency of mosaic chromosome Y loss in peripheral blood cells of aging men varies profoundly between individuals. | European Journal of Human Genetics | 2020 |
| 33236886 | Fluorine-18-Labeled Antibody Ligands for PET Imaging of Amyloid-β in Brain. | ACS Chemical Neuroscience | 2020 |
| 31386938 | Longitudinal cognitive decline in autosomal-dominant Alzheimer's disease varies with mutations in APP and PSEN1 genes. | Neurobiology of Aging | 2019 |
| 30374072 | Mosaic loss of chromosome Y in leukocytes matters. | Nature Genetics | 2019 |
| 30614806 | Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers. | J Alzheimers Dis | 2019 |
| 30820047 | Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. | Nat Genet | 2019 |
| 29793530 | Efficient clearance of Aβ protofibrils in AβPP-transgenic mice treated with a brain-penetrating bifunctional antibody. | Alzheimer's Research and Therapy | 2018 |
| 28557010 | Rapid amyloid-β oligomer and protofibril accumulation in traumatic brain injury. | Brain Pathology | 2018 |
| 29934873 | Alzheimer's disease pathology propagation by exosomes containing toxic amyloid-beta oligomers. | Acta Neuropathologica | 2018 |
| 29858078 | CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's Disease. | Mol Ther Nucleic Acids | 2018 |
| 29853653 | Antibody-Based In Vivo PET Imaging Detects Amyloid-β Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition. | | 2018 |
| 29311311 | Structural heterogeneity and intersubject variability of Aβ in familial and sporadic Alzheimer's disease. | Proc Natl Acad Sci U S A | 2018 |
| 29592816 | The Aβ protofibril selective antibody mAb158 prevents accumulation of Aβ in astrocytes and rescues neurons from Aβ-induced cell death. | Journal of Neuroinflammation | 2018 |
| 29360107 | Erratum: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls. | Sci Data | 2018 |
| 28079014 | Predicting Cognitive Decline across Four Decades in Mutation Carriers and Non-carriers in Autosomal-Dominant Alzheimer's Disease. | Journal of the International Neuropsychological Society | 2017 |
| 28341696 | A Low-Frequency Inactivating <i>AKT2</i> Variant Enriched in the Finnish Population Is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk. | Diabetes | 2017 |
| 28416818 | Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. | Nat Genet | 2017 |
| 28714976 | Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. | Nat Genet | 2017 |
| 28886705 | Cognitive function in very old men does not correlate to biomarkers of Alzheimer's disease. | BMC Geriatrics | 2017 |
| 28932173 | Efficient and inexpensive transient expression of multispecific multivalent antibodies in Expi293 cells. | Biological Procedures Online | 2017 |
| 28747752 | Erratum: Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. | Nat Genet | 2017 |
| 28566273 | An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans. | Diabetes | 2017 |
| 29040868 | Identification of a novel proinsulin-associated SNP and demonstration that proinsulin is unlikely to be a causal factor in subclinical vascular remodelling using Mendelian randomisation. | Atherosclerosis | 2017 |
| 28394258 | Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function. | J Clin Invest | 2017 |
| 29228971 | Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes. | Journal of Neuroinflammation | 2017 |
| 29257133 | Sequence data and association statistics from 12,940 type 2 diabetes cases and controls. | Sci Data | 2017 |
| 26961542 | Cellular Uptake of α-Synuclein Oligomer-Selective Antibodies is Enhanced by the Extracellular Presence of α-Synuclein and Mediated via Fcγ Receptors. | Cellular and Molecular Neurobiology | 2017 |
| 28069541 | A bispecific Tribody PET radioligand for visualization of amyloid-beta protofibrils - a new concept for neuroimaging. | NeuroImage | 2017 |
| 28265256 | Decreased HHV-6 IgG in Alzheimer's Disease. | Frontiers in Neurology | 2017 |
| 27743932 | Brain mGluR5 in mice with amyloid beta pathology studied with in vivo [C]ABP688 PET imaging and ex vivo immunoblotting. | Neuropharmacology | 2017 |
| 28042336 | Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor. | Theranostics | 2017 |